Amman: – Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic pharmaceutical company, has received a ‘B’ rating from the CDP Global Climate Change Report 2019, marking an improvement over the Company’s most recent score and placing it above the European CDP average.
CDP is an independent, not-for-profit organization aimed at enabling companies to progress towards environmental stewardship through benchmarking and comparison with peers.
Hikma was recognized for its emission reduction initiatives, governance and risk management processes, demonstrating its strong commitment and leadership in these areas. The Company also received higher-than-average marks for its work around risk disclosure, opportunity disclosure and business impact/financial planning.
“We are proud to receive this acknowledgement of the positive impact of the efforts we’ve made to improve our environmental performance,” explained Hana Ramadan, Vice President of Global Corporate Social Responsibility at Hikma. “We have amplified our efforts around sustainability, in particular to make an immediate reduction on our energy consumption levels. The recent improved score from the CDP is an important recognition of these focused efforts.”
As part of Hikma’s ‘Go Green’ initiative in 2019, the Company successfully completed its installation of photovoltaic net metering solar panels that absorb a portion of overall energy needs at facilities in Jordan and Portugal; installed charging stations for electric vehicles at Company facilities; switched its fleet of vehicles to hybrid-powered vehicles; and moved to cleaner fuel options. The Company has also elevated sustainability issues to the Compliance, Responsibility and Ethics Committee (CREC) to ensure greater Board oversight of impact efforts.
To learn more about the sustainability work at Hikma, please visit:
https://www.hikma.com/sustainability/
-Ends-
Enquiries
Hikma Pharmaceuticals PLC
Dana Alhusseini
Communication Manager
+962 6 580 2900
Dalhusseini@hikma.com
About Hikma
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
